Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$750,000 |
 |
MedtronicMDT |
-$240,000 |
 |
Edwards LifesciencesEW |
$81,000 |
 |
Intuitive SurgicalISRG |
$27,000 |
 |
ArtivionAORT |
$150,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer | Aug 5, 2024 | Buy | $1K - $15K |
| Daniel S. Goldman Democrat | Jul 12, 2023 | Sell | $1K - $15K |
Who is the latest politician to buy or sell Tandem Diabetes Care shares?
Josh Gottheimer purchased Tandem Diabetes Care shares most recently on August 5, 2024.
Which politician has bought the most TNDM stock in the last two years?
Josh Gottheimer has bought the most TNDM stock in the last 2 years, with an estimated value of $8,000.
Which politician has sold the most TNDM stock over the last two years?
Daniel S. Goldman has sold the most TNDM stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading TNDM stock in the last 2 years?
There have been no US politicians buying or selling Tandem Diabetes Care in the last 2 years.
How do insider transactions over the last 2 years reflect on Tandem Diabetes Care's market confidence?
Over the last 2 years, insider transactions for Tandem Diabetes Care have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
